JPRN-UMIN000043854尚未招募未知
A multicenter, open-label, single-blind, randomized, parallel-group study to evaluate the utility of indigocarmine and acetic acid-indigocarmine mixture (AIM) for the diagnosis of colonic serrated lesions in the right side colon - A multicenter, open-label, single-blind, randomized, parallel-group study to evaluate the utility of indigocarmine and acetic acid-indigocarmine mixture (AIM) for the diagnosis of colonic serrated lesions in the right side colon (cAIM study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 1,311
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Familial colorectal adenomatosis, Lynch syndrome, serrated polyp syndrome(SPS) (2) Patients with a history of colorectal cancer surgery (3) Patients with endoscopic treatment of the colon within 1 year (4) Ulcerative colitis and Crohn's disease (5) Difficulty with endoscopic examination and treatment due to inability to temporarily stop taking antithrombotic or anticoagulant drugs (6) Patents with an infectious disease that requires systemic treatment (7) Pregnant and lactating women (8) Patients with a history of hypersensitivity to indigocarmine or acetic acid (9) Patients who are deemed unsuitable as research subjects by the principal investigator or sub-researcher
研究者
相似试验
招募中
3 期
The usefulness of AIM in colonoscopySerrated lesionJPRN-jRCTs061210002Kinugasa Hideaki1,311
已完成
不适用
A multi-center, single-dose, open-label, randomized, parallel group study to investigate the reduction of initial taspoglutide Cmax after administration of 20 mg taspoglutide 10% Sustained Release Formulation (SRF) using three modified formulations as compared to the current Phase 3 formulation in healthy volunteers.diabetes mellitus type 210018424diabetesNL-OMON34034Hoffmann-La Roche100
进行中（未招募）
1 期
A study with dose de-escalation of coventional or biologic treatments in early rheeumatoid arthritis in patients with low disease activity.EUCTR2014-002374-36-SEThe Karolinska Institutet, ClinTRID500
进行中（未招募）
1 期
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.Rheumatoid arthritis (RA)MedDRA version: 19.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-004720-35-DKKarolinska Institutet800
已完成
4 期
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.arthritis10003816Rheumatoid ArthritisNL-OMON50439Ronald van Vollenhove/Karolinska Instituut (clinTRID)120